Glenmede Trust’s Alpine Immune Sciences Inc ALPN Stock Holding History

Glenmede Trust’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,780	Closed	-$229K	–	1438
2024 Q1	$229K	Buy	+5,780	New	+$171K	﹤0.01%	1139

Glenmede Trust's ALPN Position: Q2 2024 in Review

Glenmede Trust sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 5,780 shares — an estimated $229K sold.

Glenmede Trust first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $229K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Glenmede Trust reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Glenmede Trust sold 5,780 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $229K.
Glenmede Trust first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Glenmede Trust's Alpine Immune Sciences Inc position peaked at $229K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Glenmede Trust's 13F filing for Q2 2024, filed 14 Aug 2024.